These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12661183)

  • 1. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations.
    Olsen GW; Burris JM; Burlew MM; Mandel JH
    J Occup Environ Med; 2003 Mar; 45(3):260-70. PubMed ID: 12661183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees.
    Olsen GW; Burris JM; Mandel JH; Zobel LR
    J Occup Environ Med; 1999 Sep; 41(9):799-806. PubMed ID: 10491796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006.
    Olsen GW; Mair DC; Church TR; Ellefson ME; Reagen WK; Boyd TM; Herron RM; Medhdizadehkashi Z; Nobiletti JB; Rios JA; Butenhoff JL; Zobel LR
    Environ Sci Technol; 2008 Jul; 42(13):4989-95. PubMed ID: 18678038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.
    Olsen GW; Butenhoff JL; Zobel LR
    Reprod Toxicol; 2009 Jun; 27(3-4):212-230. PubMed ID: 19429401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers.
    Olsen GW; Burris JM; Ehresman DJ; Froehlich JW; Seacat AM; Butenhoff JL; Zobel LR
    Environ Health Perspect; 2007 Sep; 115(9):1298-305. PubMed ID: 17805419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.
    Kannan K; Corsolini S; Falandysz J; Fillmann G; Kumar KS; Loganathan BG; Mohd MA; Olivero J; Van Wouwe N; Yang JH; Aldoust KM
    Environ Sci Technol; 2004 Sep; 38(17):4489-95. PubMed ID: 15461154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.
    Midasch O; Schettgen T; Angerer J
    Int J Hyg Environ Health; 2006 Nov; 209(6):489-96. PubMed ID: 16872899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors.
    Olsen GW; Mair DC; Reagen WK; Ellefson ME; Ehresman DJ; Butenhoff JL; Zobel LR
    Chemosphere; 2007 May; 68(1):105-11. PubMed ID: 17267015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington.
    Olsen GW; Church TR; Larson EB; van Belle G; Lundberg JK; Hansen KJ; Burris JM; Mandel JH; Zobel LR
    Chemosphere; 2004 Mar; 54(11):1599-611. PubMed ID: 14675839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption of seafood, serum liver enzymes, and blood levels of PFOS and PFOA in the Japanese population.
    Yamaguchi M; Arisawa K; Uemura H; Katsuura-Kamano S; Takami H; Sawachika F; Nakamoto M; Juta T; Toda E; Mori K; Hasegawa M; Tanto M; Shima M; Sumiyoshi Y; Morinaga K; Kodama K; Suzuki T; Nagai M; Satoh H
    J Occup Health; 2013; 55(3):184-94. PubMed ID: 23574777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions.
    Butenhoff JL; Pieterman E; Ehresman DJ; Gorman GS; Olsen GW; Chang SC; Princen HM
    Toxicol Lett; 2012 May; 210(3):360-5. PubMed ID: 22387339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years.
    Harada K; Saito N; Inoue K; Yoshinaga T; Watanabe T; Sasaki S; Kamiyama S; Koizumi A
    J Occup Health; 2004 Mar; 46(2):141-7. PubMed ID: 15090689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities.
    Olsen GW; Ehresman DJ; Buehrer BD; Gibson BA; Butenhoff JL; Zobel LR
    J Occup Environ Med; 2012 Aug; 54(8):974-83. PubMed ID: 22842914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan.
    Harada K; Koizumi A; Saito N; Inoue K; Yoshinaga T; Date C; Fujii S; Hachiya N; Hirosawa I; Koda S; Kusaka Y; Murata K; Omae K; Shimbo S; Takenaka K; Takeshita T; Todoriki H; Wada Y; Watanabe T; Ikeda M
    Chemosphere; 2007 Jan; 66(2):293-301. PubMed ID: 16793116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood.
    Olsen GW; Huang HY; Helzlsouer KJ; Hansen KJ; Butenhoff JL; Mandel JH
    Environ Health Perspect; 2005 May; 113(5):539-45. PubMed ID: 15866760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers.
    Olsen GW; Zobel LR
    Int Arch Occup Environ Health; 2007 Nov; 81(2):231-46. PubMed ID: 17605032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers.
    Olsen GW; Burris JM; Burlew MM; Mandel JH
    Drug Chem Toxicol; 2000 Nov; 23(4):603-20. PubMed ID: 11071397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals.
    Ehresman DJ; Froehlich JW; Olsen GW; Chang SC; Butenhoff JL
    Environ Res; 2007 Feb; 103(2):176-84. PubMed ID: 16893538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.
    Frisbee SJ; Shankar A; Knox SS; Steenland K; Savitz DA; Fletcher T; Ducatman AM
    Arch Pediatr Adolesc Med; 2010 Sep; 164(9):860-9. PubMed ID: 20819969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population.
    Eriksen KT; Raaschou-Nielsen O; McLaughlin JK; Lipworth L; Tjønneland A; Overvad K; Sørensen M
    PLoS One; 2013; 8(2):e56969. PubMed ID: 23441227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.